Finland is offering farmworkers bird flu shots. Some experts say the US should, too – ABC News
							July 12, 2024
							    This is a KFF Health News story.  
    As bird flu spreads among dairy cattle in the U.S.,    veterinarians and researchers have taken note of Finland's move    to vaccinate farmworkers at risk of infection. They wonder why    their government doesn't do the same.  
    "Farmworkers, veterinarians, and producers are handling large    volumes of milk that can contain high levels of bird flu    virus," said Kay Russo, a livestock and poultry veterinarian in    Fort Collins, Colorado. "If a vaccine seems to provide some    immunity, I think it should be offered to them."  
    Amon a dozen virology and outbreak experts interviewed by KFF    Health News, most agree with Russo. They said people who work    with dairy cows should be offered vaccination for a disease    that has killed roughly half of the people known to have gotten    it globally over the past two decades, has killed cats in the    U.S. this year, and has pandemic potential.  
    However, some researchers sided with the Centers for Disease    Control and Prevention (CDC) in recommending against    vaccination for now. There's no evidence that this year's bird    flu virus spreads between people or causes serious disease in    humans. And it's unclear how well the available vaccine would    prevent either scenario.  
    But the wait-and-see approach "is a gamble," said Jennifer    Nuzzo, director of the Pandemic Center at Brown University. "By    the time we see severe outcomes, it means a lot of people have    been infected."  
    "Now is the time to offer the vaccines to farmworkers in the    United States," said Nahid Bhadelia, director of the Boston    University Center on Emerging Infectious Diseases. Even more    urgent measures are lagging in the U.S., she added. Testing of    farmworkers and cows is sorely needed to detect the H5N1 bird    flu virus, study it, and extinguish it before it becomes a    fixture on farms -- posing an ever-present pandemic threat.  
    Demetre Daskalakis, director of the CDC's National Center for    Immunization and Respiratory Diseases, said the agency takes    bird flu seriously, and the U.S. is stockpiling     4.8 million doses of the vaccine. But, he said, "there's no    recommendation to launch a vaccine campaign."  
    "It's all about risk-benefit ratios," Daskalakis said. The    benefits are blurry because there     hasn't been enough testing to understand how easily the    virus jumps from cows into people, and how sick they become.    Just four people in the United States have tested positive this    year, with mild cases -- too few to draw conclusions.  
    Other farmworkers and veterinarians working on dairy farms with    outbreaks have reported being sick, Russo said, but they    haven't been tested. Public health labs have tested only about    50 people for the bird flu since the outbreak was detected in    March.  
    Still, Daskalakis said the CDC is not concerned that the agency    is missing worrisome bird flu infections because of its    influenza surveillance system. Hospitals report patients with    severe cases of flu, and numbers are normal this year.  
    Another signal that puts the agency at ease is that the virus    doesn't yet have mutations that allow it to spread rapidly    between people as they sneeze and breathe. "If we start to see    changes in the virus, that's another factor that would be part    of the decision to move from a planning phase into an    operational one," Daskalakis said.  
    On July 8, researchers    reported that the virus may be closer to spreading between    people than previously thought. It still doesn't appear to do    so, but experiments suggest it has the ability to infect human    airways. It also spread between two laboratory ferrets through    the air.  
    In considering vaccines, the agency takes a cue from a 1976    outbreak of the swine flu. Officials initially feared a repeat    of the 1918 swine flu pandemic that killed roughly half a    million people in the United States. So they rapidly vaccinated    nearly 43 million people in the country within a year.  
    But swine flu cases turned out to be mild that year. This made    the vaccine seem unnecessarily risky as several reports of a    potentially deadly disorder, Guillain-Barr Syndrome, emerged.    Roughly one of every    million people who get influenza vaccines may acquire the    disorder, according to the CDC. That risk is outweighed by the    benefits of prevention. Since Oct. 1,     as many as 830,000 people have been hospitalized for the    seasonal flu and 25,000 to 75,000 people have died.  
    An     after-action report on the 1976 swine flu situation called    it a "sobering, cautionary tale" about responding prematurely    to an uncertain public health threat. "It's a story about what    happens when you launch a vaccine program where you are    accepting risk without any benefit," Daskalakis said.  
    Paul Offit, a virologist at the Children's Hospital of    Philadelphia, sides with the CDC. "I'd wait for more data," he    said.  
    However, other researchers say this isn't comparable to 1976    because they aren't suggesting that the U.S. vaccinate tens of    millions of people. Rather they're talking about a voluntary    vaccine for thousands of people in close contact with    livestock. This lessens the chance of rare adverse effects.  
    The bird flu vaccine on hand, made by the flu vaccine company    CSL Seqirus, was     authorized last year by the European equivalent of the FDA.    An older variety has FDA approval, but the newer variety hasn't    gotten the green light yet.  
    Although the vaccine targets a different bird flu strain than    the H5N1 virus now circulating in cows, studies show it    triggers an immune response against both varieties. It's    considered safe because it uses the same     egg-based vaccine technology deployed every year in    seasonal flu vaccines.  
    For these reasons, the United States, the United Kingdom, the    Netherlands, and     about a dozen other countries are stockpiling millions of    doses. Finland expects to offer them to people who work on fur    farms this month as a precaution because its mink and fox farms    were hit by the bird flu last year.  
    In contrast, mRNA vaccines being developed against the bird flu    would be a first for influenza. On July 2, the U.S. government    announced that it would pay Moderna $176 million for their    development, and that the vaccines may enter clinical trials    next year. Used widely against covid-19, this newer technology    uses mRNA to teach the immune system how to recognize    particular viruses.  
    In the meantime, Florian Krammer, a flu virologist at Mount    Sinai's Icahn School of Medicine, said people who work on dairy    farms should have the option to get the egg-based vaccine. It    elicits an immune response against a primary component of the    H5N1 bird flu virus that should confer a degree of protection    against infection and serious sickness, he said.  
    Still, its protection wouldn't be 100%. And no one knows how    many cases and hospitalizations it would prevent since it    hasn't been used to combat this year's virus. Such data should    be collected in studies that track the outcomes of people who    opt to get one, he said.  
    Krammer isn't assuaged by the lack of severe bird flu cases    spotted in clinics. "If you see a signal in hospitals, the cat    is out of the bag. Game over, we have a pandemic," he said.    "That's what we want to avoid."  
    He and others stressed that the United States should be doing    everything it can to curb infections before flu season starts    in October. The vaccine could provide an additional layer of    protection on top of testing, wearing gloves, and goggles, and    disinfecting milking equipment. Scientists worry that if people    get the bird flu and the seasonal flu simultaneously, bird flu    viruses could snag adaptations from seasonal viruses that allow    them to spread swiftly among humans.  
    They also note it could take months to distribute the vaccines    after they're recommended since it requires outreach. People    who work beside dairy cows still lack information on the virus,    four months into this outbreak, said Bethany Boggess Alcauter,    director of research at the National Center for Farmworker    Health.  
    Health officials have talked with dairy farm owners, but    Boggess' interviews with farmworkers suggest those    conversations haven't trickled down to their staff. One    farmworker in the     Texas Panhandle told her he was directed to disinfect his    hands and boots to protect cows from diseases that workers may    carry. "They never told us if the cow could infect us with some    illness," the farmworker said in Spanish.  
    The slow pace of educational outreach is a reminder that    everything takes time, including vaccine decisions. When    deciding whether to recommend vaccines, the CDC typically seeks    guidance from its Advisory Committee on Immunization Practices,    or the ACIP. A consultant to the group, infectious disease    researcher William Schaffner, has repeatedly asked the agency    to present its thinking on Seqirus' bird flu vaccine.  
    Rather than fret about the 1976 swine flu situation, Schaffner    suggested the CDC consider the 2009-10 swine flu pandemic. It    caused more than 274,000 hospitalizations and 12,000 deaths in    the U.S. within a year. By the time vaccines were rolled out,    he said, much of the damage had been done.  
    "The time to discuss this with ACIP is now," said Schaffner,    before the bird flu becomes a public health emergency. "We    don't want to discuss this until the cows come home in the    middle of a crisis."  
View post:
Finland is offering farmworkers bird flu shots. Some experts say the US should, too - ABC News